Taipei, May 23 (CNA) The Taiwan Food and Drug Administration (TFDA) announced Wednesday that two measures have been implemented to increase intravenous (IV) fluid supplies after a halt in production by Taiwan's major saline supplier sparked concerns
Related
Next